Using the HIF-1α deficient cell line, 786-O, Hu et al [64] demonstrated that HIF-1α distinctly regulates the expression of mRNA encoding enzymes in the glycolytic pathway while HIF-2α promotes tumour growth/progression, a distinctly different function. Here, EPAS1 is linked to neoplasm.